No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr6:36655000-36672000 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
2 |
chr6:36661400-36696400 |
Weak transcription |
Right Atrium |
heart
|
3 |
chr6:36666600-36670800 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
4 |
chr6:36666600-36671000 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
5 |
chr6:36666800-36670000 |
Enhancers |
Primary B cells from cord blood |
blood
|
6 |
chr6:36667000-36671400 |
Weak transcription |
Primary mononuclear cells fromperipheralblood |
Blood
|
7 |
chr6:36667600-36669800 |
Enhancers |
Stomach Mucosa |
stomach
|
8 |
chr6:36667800-36670200 |
Weak transcription |
Fetal Intestine Large |
intestine
|
9 |
chr6:36668400-36669800 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
10 |
chr6:36668400-36669800 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
11 |
chr6:36668400-36669800 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
12 |
chr6:36668600-36669600 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
13 |
chr6:36668600-36669800 |
Enhancers |
Primary B cells from peripheral blood |
blood
|
14 |
chr6:36668600-36669800 |
Genic enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
15 |
chr6:36668600-36669800 |
Enhancers |
NHEK |
skin
|
16 |
chr6:36668600-36670000 |
Enhancers |
HMEC |
breast
|
17 |
chr6:36668600-36670400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
18 |
chr6:36668800-36669800 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
19 |
chr6:36668800-36670000 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
20 |
chr6:36668800-36670400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
21 |
chr6:36669000-36669600 |
Bivalent Enhancer |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
22 |
chr6:36669000-36669600 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
23 |
chr6:36669000-36669600 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
24 |
chr6:36669000-36669600 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
25 |
chr6:36669000-36670000 |
Enhancers |
HSMM |
muscle
|
26 |
chr6:36669200-36669600 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
27 |
chr6:36669200-36669600 |
Enhancers |
Hela-S3 |
cervix
|
28 |
chr6:36669200-36669600 |
Enhancers |
HUVEC |
blood vessel
|
29 |
chr6:36669200-36669600 |
Enhancers |
Osteobl |
bone
|
30 |
chr6:36669200-36669800 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
31 |
chr6:36669200-36669800 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
32 |
chr6:36669400-36669600 |
Enhancers |
Fetal Heart |
heart
|
33 |
chr6:36669400-36669600 |
Enhancers |
Placenta |
Placenta
|
34 |
chr6:36669400-36669600 |
Enhancers |
Gastric |
stomach
|
35 |
chr6:36669400-36670000 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
36 |
chr6:36669400-36670600 |
Enhancers |
Spleen |
Spleen
|